Sichuan Fengchun Pharmaceutical Co., Ltd.
Sichuan Fengchun Pharmaceutical Co., Ltd. (abbreviated as Fengchun/Fengchun Pharmaceutical) was founded in 1973 and completed its strategic restructuring in 2000 after the restructuring of the former Zhongjiang Pharmaceutical Factory. Now, a modern private enterprise has been formed that integrates pharmaceutical research, industrial production, pharmaceutical sales, agricultural breeding, big health industry, and project investment. As a long-standing pharmaceutical company in Kawachi, it has been devoted to inheriting the innovative development of traditional Chinese medicine and modern medicine. At present, it has 4 GMP production factories (including well-known subsidiaries such as Jiuzhaigou Natural Pharmaceutical and Sichuan Shenghe Pharmaceutical); more than 20 breeding companies; more than 5,000 employees; the company, wholly-owned subsidiaries and shareholders have assets of nearly 30 RMB 100 million; more than 1,500 mu of industrial land, with an industrial construction area of more than 330,000 square meters; more than 230,000 mu of GAP planting land, forestry and aquaculture land. In 2014, Fengchun acquired Jiuzhaigou Natural Pharmaceutical Co., Ltd. and its four wholly-owned subsidiaries; in early 2020, Fengchun Holdings Sichuan Shenghe Pharmaceutical Co., Ltd. and its two wholly-owned subsidiaries: 2021 Sichuan Fengchuntang Chinese Medicine Decoction Co., Ltd. was established in 2022 and passed the GMP certification, committed to creating Chinese medicine fine decoctions. At this point, Fengchun has taken solid steps in building a traditional Chinese and Western medicine industry with domestic first-class R&D capabilities, extremely large production scale and characteristics, as well as the Qiang and Tibetan ethnic pharmaceutical industries. At present, its pharmaceutical companies have 114 invention patents and 403 drug production approval documents. In order to sustainable protection and utilization of scarce traditional Chinese medicine resources, its Sichuan Fengchun Musk Industry Group has been established and approved 13 artificially bred forest musk and horse musk subsidiaries, and another 7 are under construction. Jiuzhaigou Natural Pharmaceutical Co., Ltd., a subsidiary, is one of more than 10 pharmaceutical companies approved to use natural musk in China recently, and is also a pharmaceutical company approved to use natural musk as a drug product in China.
Sichuan Fengchun Pharmaceutical Co., Ltd.
Sichuan Fengchun Pharmaceutical Co., Ltd. (abbreviated as Fengchun/Fengchun Pharmaceutical) was founded in 1973 and completed its strategic restructuring in 2000 after the restructuring of the former Zhongjiang Pharmaceutical Factory. Now, a modern private enterprise has been formed that integrates pharmaceutical research, industrial production, pharmaceutical sales, agricultural breeding, big health industry, and project investment. As a long-standing pharmaceutical company in Kawachi, it has been devoted to inheriting the innovative development of traditional Chinese medicine and modern medicine. At present, it has 4 GMP production factories (including well-known subsidiaries such as Jiuzhaigou Natural Pharmaceutical and Sichuan Shenghe Pharmaceutical); more than 20 breeding companies; more than 5,000 employees; the company, wholly-owned subsidiaries and shareholders have assets of nearly 30 RMB 100 million; more than 1,500 mu of industrial land, with an industrial construction area of more than 330,000 square meters; more than 230,000 mu of GAP planting land, forestry and aquaculture land. In 2014, Fengchun acquired Jiuzhaigou Natural Pharmaceutical Co., Ltd. and its four wholly-owned subsidiaries; in early 2020, Fengchun Holdings Sichuan Shenghe Pharmaceutical Co., Ltd. and its two wholly-owned subsidiaries: 2021 Sichuan Fengchuntang Chinese Medicine Decoction Co., Ltd. was established in 2022 and passed the GMP certification, committed to creating Chinese medicine fine decoctions. At this point, Fengchun has taken solid steps in building a traditional Chinese and Western medicine industry with domestic first-class R&D capabilities, extremely large production scale and characteristics, as well as the Qiang and Tibetan ethnic pharmaceutical industries. At present, its pharmaceutical companies have 114 invention patents and 403 drug production approval documents. In order to sustainable protection and utilization of scarce traditional Chinese medicine resources, its Sichuan Fengchun Musk Industry Group has been established and approved 13 artificially bred forest musk and horse musk subsidiaries, and another 7 are under construction. Jiuzhaigou Natural Pharmaceutical Co., Ltd., a subsidiary, is one of more than 10 pharmaceutical companies approved to use natural musk in China recently, and is also a pharmaceutical company approved to use natural musk as a drug product in China.
WeBrew, found by a crew of craft brewing veterans, is a prime brewing equipment provider for craft brewing industry. WeBrew products include but not limited to Brewhouses, Uni-tanks, Brite Tanks, HLT/CLT, Keg Washers etc. We also work on special project according to customers' requirements.
At WeBrew, we are at the heart of everything we do. WeBrew is also proud to partner with SEW, Midco, Siemens and more for the next level brewing equipment manufacturing. Our extraordinary equipment have always been designed and built by exceptional people using only the finest of materials and they have always been used by exceptional people, too.
As a brand we are constantly looking forward to improve ourselves and to grow with our customers. At WeBrew, we are here for one reason, to build the best brewing equipment we can. We are born to brew and we are WeBrew!
WeBrew
WeBrew, found by a crew of craft brewing veterans, is a prime brewing equipment provider for craft brewing industry. WeBrew products include but not limited to Brewhouses, Uni-tanks, Brite Tanks, HLT/CLT, Keg Washers etc. We also work on special project according to customers' requirements.
At WeBrew, we are at the heart of everything we do. WeBrew is also proud to partner with SEW, Midco, Siemens and more for the next level brewing equipment manufacturing. Our extraordinary equipment have always been designed and built by exceptional people using only the finest of materials and they have always been used by exceptional people, too.
As a brand we are constantly looking forward to improve ourselves and to grow with our customers. At WeBrew, we are here for one reason, to build the best brewing equipment we can. We are born to brew and we are WeBrew!
Jiuzhaigou Natural Pharmaceutical Co., Ltd.
Jiuzhaigou Natural Pharmaceutical Co., Ltd. is a national designated manufacturer of national national medicines, a science and technology innovation enterprise in Sichuan Province, and is currently a wholly-owned subsidiary of Sichuan Fengchun Pharmaceutical Group. Jiuyao’s predecessor was Aba Prefecture Pharmaceutical Factory in Sichuan Province. It was founded in 1970. Over the years, the company has based on resource advantages and relying on technological progress, and its scale and strength have been continuously growing. The company makes full use of the unique medicinal resources of "Snow Mountain Grassland" to develop and produce 59 Chinese and Tibetan patent medicines and Western medicines in 11 dosage forms. Varieties such as "獐子子" and "Jiuzhaigou" brand Xiaojin Wan, Xihuang Wan, Niuhuang Xingxiao Wan have won various awards from the state and provincial levels. Chuanbei Sydney Pear Paste, Wuwei Musk Pills, Xiao Chaihu Tablets, and Lianpu Shuangqing Tablets have successively been followed. It was rated as a national protected variety of traditional Chinese medicine; the company was shortlisted in the top 30 large-scale pharmaceutical industry enterprises in Sichuan in 1997, with a large market share of the top 30, etc. In 2008, the company's Yingxiu production base was destroyed during the "May 12" Wenchuan earthquake. Jiuyao people rushed to produce and save themselves in the face of disasters and grief. At present, the Xuankou production base and Jiuyao Deyang Branch have been built.
Jiuzhaigou Natural Pharmaceutical Co., Ltd.
Jiuzhaigou Natural Pharmaceutical Co., Ltd. is a national designated manufacturer of national national medicines, a science and technology innovation enterprise in Sichuan Province, and is currently a wholly-owned subsidiary of Sichuan Fengchun Pharmaceutical Group. Jiuyao’s predecessor was Aba Prefecture Pharmaceutical Factory in Sichuan Province. It was founded in 1970. Over the years, the company has based on resource advantages and relying on technological progress, and its scale and strength have been continuously growing. The company makes full use of the unique medicinal resources of "Snow Mountain Grassland" to develop and produce 59 Chinese and Tibetan patent medicines and Western medicines in 11 dosage forms. Varieties such as "獐子子" and "Jiuzhaigou" brand Xiaojin Wan, Xihuang Wan, Niuhuang Xingxiao Wan have won various awards from the state and provincial levels. Chuanbei Sydney Pear Paste, Wuwei Musk Pills, Xiao Chaihu Tablets, and Lianpu Shuangqing Tablets have successively been followed. It was rated as a national protected variety of traditional Chinese medicine; the company was shortlisted in the top 30 large-scale pharmaceutical industry enterprises in Sichuan in 1997, with a large market share of the top 30, etc. In 2008, the company's Yingxiu production base was destroyed during the "May 12" Wenchuan earthquake. Jiuyao people rushed to produce and save themselves in the face of disasters and grief. At present, the Xuankou production base and Jiuyao Deyang Branch have been built.
Guangdong Shaxi Pharmaceutical Co., Ltd.
Guangdong Shaxi Pharmaceutical Co., Ltd. (formerly Shaxi Pharmaceutical Factory, Zhongshan City, Guangdong Province), is a private technology enterprise in Guangdong Province. It was founded in 1907 and has a history of more than 130 years. Over the years, it has been keen on reform, constantly developing and insisting on technology. Xing Company's road to quality victory has enabled the company to develop into a modern medium-sized pharmaceutical enterprise with advanced production and inspection equipment. In January 2022, it officially became a wholly-owned subsidiary of the listed company Jingxin Pharmaceutical (stock code: 002020). The company produces tablets, capsules, pills (honey pills, water honey pills, water pills, concentrated pills), granules, tea bags, decocted tea, syrup, and decoction paste, a total of 149 Chinese patent medicine products. Including 47 "National Basic Medicines" and 31 supplementary basic medicines in Guangdong Province. The traditional product "Shaxi Herbal Tea Series Products" has been included in the Guangdong Province and the National Intangible Cultural Heritage List. The honors and rewards that have been awarded over the years include: China's contract-abiding and credit-abiding enterprises, Guangdong Province's contract-abiding and credit-abiding enterprises for 22 consecutive years, Zhongshan City's civilized unit, Zhongshan City's environmental protection and integrity enterprise, Zhongshan City's outstanding private enterprise "Glory Star", Zhongshan City price integrity unit, etc. After review and establishment of Zhongshan Enterprise Technology Center and Zhongshan Engineering Technology Research and Development Center, the Zhongshan Municipal People's Government has carried out industry-university-research activities. The national third-class new drug "Runchan Ningshen Paste" was developed and successfully included in the national traditional Chinese medicine protected variety. , This product won the third prize of Guangdong Province Science and Technology. Due to its stable quality and significant efficacy, the products are sold well all over the country and are also sold to Southeast Asia, Hong Kong, Macao, Europe and the United States and other countries and regions. The headquarter Zhejiang Jingxin Pharmaceutical Co., Ltd. is a professional pharmaceutical listed company and a national key high-tech enterprise. The solid preparation has passed the German (EU) GMP certification and has a postdoctoral research workstation. The company has four major production bases in Xinchang, Shangyu, Jiangxi, Shangrao, and Inner Mongolia. It has R&D centers and marketing centers in Shanghai and Hangzhou respectively. Its business network covers the whole country and has extensive international sales channels. Jingxin Pharmaceutical takes "creating excellent enterprises and establishing Jingxin brand" as its core business philosophy and "Beijing New Drugs, carefully created" as its brand philosophy. Jingxin Pharmaceuticals has the courage and determination to "standing at the forefront of the world and be a pioneer in the pharmaceutical industry" , committed to developing the pharmaceutical industry, contribute to the society with outstanding products, and strive to make continuous new contributions to human health.
Guangdong Shaxi Pharmaceutical Co., Ltd.
Guangdong Shaxi Pharmaceutical Co., Ltd. (formerly Shaxi Pharmaceutical Factory, Zhongshan City, Guangdong Province), is a private technology enterprise in Guangdong Province. It was founded in 1907 and has a history of more than 130 years. Over the years, it has been keen on reform, constantly developing and insisting on technology. Xing Company's road to quality victory has enabled the company to develop into a modern medium-sized pharmaceutical enterprise with advanced production and inspection equipment. In January 2022, it officially became a wholly-owned subsidiary of the listed company Jingxin Pharmaceutical (stock code: 002020). The company produces tablets, capsules, pills (honey pills, water honey pills, water pills, concentrated pills), granules, tea bags, decocted tea, syrup, and decoction paste, a total of 149 Chinese patent medicine products. Including 47 "National Basic Medicines" and 31 supplementary basic medicines in Guangdong Province. The traditional product "Shaxi Herbal Tea Series Products" has been included in the Guangdong Province and the National Intangible Cultural Heritage List. The honors and rewards that have been awarded over the years include: China's contract-abiding and credit-abiding enterprises, Guangdong Province's contract-abiding and credit-abiding enterprises for 22 consecutive years, Zhongshan City's civilized unit, Zhongshan City's environmental protection and integrity enterprise, Zhongshan City's outstanding private enterprise "Glory Star", Zhongshan City price integrity unit, etc. After review and establishment of Zhongshan Enterprise Technology Center and Zhongshan Engineering Technology Research and Development Center, the Zhongshan Municipal People's Government has carried out industry-university-research activities. The national third-class new drug "Runchan Ningshen Paste" was developed and successfully included in the national traditional Chinese medicine protected variety. , This product won the third prize of Guangdong Province Science and Technology. Due to its stable quality and significant efficacy, the products are sold well all over the country and are also sold to Southeast Asia, Hong Kong, Macao, Europe and the United States and other countries and regions. The headquarter Zhejiang Jingxin Pharmaceutical Co., Ltd. is a professional pharmaceutical listed company and a national key high-tech enterprise. The solid preparation has passed the German (EU) GMP certification and has a postdoctoral research workstation. The company has four major production bases in Xinchang, Shangyu, Jiangxi, Shangrao, and Inner Mongolia. It has R&D centers and marketing centers in Shanghai and Hangzhou respectively. Its business network covers the whole country and has extensive international sales channels. Jingxin Pharmaceutical takes "creating excellent enterprises and establishing Jingxin brand" as its core business philosophy and "Beijing New Drugs, carefully created" as its brand philosophy. Jingxin Pharmaceuticals has the courage and determination to "standing at the forefront of the world and be a pioneer in the pharmaceutical industry" , committed to developing the pharmaceutical industry, contribute to the society with outstanding products, and strive to make continuous new contributions to human health.
Henan Pijiang Technology Development Co., Ltd.
Henan Pijiang Technology Development Co., Ltd. is a professional manufacture of beer brewing equipment.As the biggest scale manufacture in China,Pijiang company was established in 2011.Advanced brewing equipment with independent intellectual property rights ensures beer quality stability, mellow taste, high brewing efficiency and save labor cost.
Henan Pijiang Technology Development Co., Ltd.
Henan Pijiang Technology Development Co., Ltd. is a professional manufacture of beer brewing equipment.As the biggest scale manufacture in China,Pijiang company was established in 2011.Advanced brewing equipment with independent intellectual property rights ensures beer quality stability, mellow taste, high brewing efficiency and save labor cost.
Hainan Calabash Kids Pharmaceutical Group Co., Ltd.
Guangxi Weiwei Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Huluwa Pharmaceutical Group. In November 2015, Huluwa Pharmaceutical Group successfully acquired 64 product approval documents and all sales networks of Nanning Weiwei Pharmaceutical Co., Ltd. and established Guangxi Weiwei Pharmaceutical Co., Ltd. In order to meet the market needs and better promote the modernization and standardization of traditional Chinese medicine, in 2016, Huluwa Pharmaceutical Group invested 250 million yuan in Nanning National Economic and Technological Development Zone to build the Nanning Production Base Project of the "Huluwa" brand series of medicines, and devoted its efforts to build the Nanning Production Base Project. Become the largest production base for children's Chinese patent medicines in China. The Nanning Production Base Project of the "Culuwa" brand series of medicines covers an area of about 48 mu. It started construction in November 2016, obtained the drug GMP certification in July 2018, and was put into production in August 2018. In 2020, Huluwa Pharmaceutical Group invested again 330 million yuan to build the second phase of Nanning production base project. The project uses about 41.78 mu of land and construction has started. The second phase of Huluwa Nanning Production Base project is another masterpiece of Huluwa Pharmaceutical Group for implementing the "China Children's Medicine National Brand Strategy", and is of great strategic significance for the group's future development and the expansion of the pharmaceutical industry scale of the Economic and Technological Development Zone. In addition, the group has also built a traditional Chinese medicine extract production base project in Laibin City, which is a supporting project of the Nanning production base. Guangxi Weiwei Pharmaceutical Co., Ltd. has always adhered to the corporate mission of "Healthy Chinese Babies" and has an intelligent production line, strictly implements the GMP quality assurance system to ensure excellent drug quality. At present, the company has 64 product approval documents, covering all provinces across the country. , municipal and county hospitals, chains, single pharmacies, etc. From the establishment of the factory to the present, Guangxi Weiwei has risen rapidly with a steady development speed and has grown into a benchmark enterprise in Guangxi's pharmaceutical industry. The company is built by Huluwa Pharmaceutical Group The production base of children's Chinese patent medicines carries the production and research and development of key products under the children's medicine brand in the future, laying a solid foundation for Huluwa Pharmaceutical Group to build the first brand of children's medicine in China. In the future, the foundation will be continuously consolidated and added We will strive to achieve high-quality development of enterprises and contribute greater strength to Nanning's economic construction.
Hainan Calabash Kids Pharmaceutical Group Co., Ltd.
Guangxi Weiwei Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Huluwa Pharmaceutical Group. In November 2015, Huluwa Pharmaceutical Group successfully acquired 64 product approval documents and all sales networks of Nanning Weiwei Pharmaceutical Co., Ltd. and established Guangxi Weiwei Pharmaceutical Co., Ltd. In order to meet the market needs and better promote the modernization and standardization of traditional Chinese medicine, in 2016, Huluwa Pharmaceutical Group invested 250 million yuan in Nanning National Economic and Technological Development Zone to build the Nanning Production Base Project of the "Huluwa" brand series of medicines, and devoted its efforts to build the Nanning Production Base Project. Become the largest production base for children's Chinese patent medicines in China. The Nanning Production Base Project of the "Culuwa" brand series of medicines covers an area of about 48 mu. It started construction in November 2016, obtained the drug GMP certification in July 2018, and was put into production in August 2018. In 2020, Huluwa Pharmaceutical Group invested again 330 million yuan to build the second phase of Nanning production base project. The project uses about 41.78 mu of land and construction has started. The second phase of Huluwa Nanning Production Base project is another masterpiece of Huluwa Pharmaceutical Group for implementing the "China Children's Medicine National Brand Strategy", and is of great strategic significance for the group's future development and the expansion of the pharmaceutical industry scale of the Economic and Technological Development Zone. In addition, the group has also built a traditional Chinese medicine extract production base project in Laibin City, which is a supporting project of the Nanning production base. Guangxi Weiwei Pharmaceutical Co., Ltd. has always adhered to the corporate mission of "Healthy Chinese Babies" and has an intelligent production line, strictly implements the GMP quality assurance system to ensure excellent drug quality. At present, the company has 64 product approval documents, covering all provinces across the country. , municipal and county hospitals, chains, single pharmacies, etc. From the establishment of the factory to the present, Guangxi Weiwei has risen rapidly with a steady development speed and has grown into a benchmark enterprise in Guangxi's pharmaceutical industry. The company is built by Huluwa Pharmaceutical Group The production base of children's Chinese patent medicines carries the production and research and development of key products under the children's medicine brand in the future, laying a solid foundation for Huluwa Pharmaceutical Group to build the first brand of children's medicine in China. In the future, the foundation will be continuously consolidated and added We will strive to achieve high-quality development of enterprises and contribute greater strength to Nanning's economic construction.
Guangdong Hengcheng Pharmaceutical Co., Ltd.
Guangdong Hengcheng Pharmaceutical Co., Ltd. was established in 2003. It was formed by the former Zhanjiang Xiangyang Pharmaceutical Co., Ltd. and Zhanjiang Zhongcheng Pharmaceutical Co., Ltd. with a long history of pharmaceuticals. It is a comprehensive combination of drug research and development, production and sales. sex pharmaceutical companies. After more than ten years of development, the company and affiliated companies have formed Hengcheng Pharmaceutical Group. Currently, Hengcheng Pharmaceutical Group is affiliated with Guangdong Hengcheng Pharmaceutical Co., Ltd., Guangdong Yihe Pharmaceutical Co., Ltd., Shaanxi Hengcheng Pharmaceutical Co., Ltd., Hengcheng Pharmaceutical Group Huainan Co., Ltd., Hainan Sanye Pharmaceutical Factory Co., Ltd., and five pharmaceutical subsidies. The company's products cover 15 dosage forms such as Western medicine raw materials, tablets, capsules, granules, etc., with about 400 approval numbers and 15 exclusive approval documents. The product sales network covers the whole country, and some products are exported to Germany and Southeast Asia. Standing at a new starting point, the company will uphold the spirit of "perseverance, integrity, self-improvement and innovation", survive with quality, develop with scientific and technological innovation, protect human health and promote Chinese traditional medical culture as its purpose, and continue to be with medicine. Colleagues from all walks of life in the field work together to create prosperity in the pharmaceutical industry.
Guangdong Hengcheng Pharmaceutical Co., Ltd.
Guangdong Hengcheng Pharmaceutical Co., Ltd. was established in 2003. It was formed by the former Zhanjiang Xiangyang Pharmaceutical Co., Ltd. and Zhanjiang Zhongcheng Pharmaceutical Co., Ltd. with a long history of pharmaceuticals. It is a comprehensive combination of drug research and development, production and sales. sex pharmaceutical companies. After more than ten years of development, the company and affiliated companies have formed Hengcheng Pharmaceutical Group. Currently, Hengcheng Pharmaceutical Group is affiliated with Guangdong Hengcheng Pharmaceutical Co., Ltd., Guangdong Yihe Pharmaceutical Co., Ltd., Shaanxi Hengcheng Pharmaceutical Co., Ltd., Hengcheng Pharmaceutical Group Huainan Co., Ltd., Hainan Sanye Pharmaceutical Factory Co., Ltd., and five pharmaceutical subsidies. The company's products cover 15 dosage forms such as Western medicine raw materials, tablets, capsules, granules, etc., with about 400 approval numbers and 15 exclusive approval documents. The product sales network covers the whole country, and some products are exported to Germany and Southeast Asia. Standing at a new starting point, the company will uphold the spirit of "perseverance, integrity, self-improvement and innovation", survive with quality, develop with scientific and technological innovation, protect human health and promote Chinese traditional medical culture as its purpose, and continue to be with medicine. Colleagues from all walks of life in the field work together to create prosperity in the pharmaceutical industry.
Sichuan Tailuo Pharmaceutical Co., Ltd.
Sichuan Taile Pharmaceutical Co., Ltd. was established in June 1999. It is a national high-tech enterprise mainly producing and selling traditional Chinese medicine granules, capsules and tablets. Located in Suining Economic and Technological Development Zone, the hometown of Guanyin in China, the company adheres to the business philosophy of "production according to law and establishing business honestly", and integrates the purpose of "making high-quality and secure medicines and protecting human health" into the entire process of enterprise production and operation. The company's factory covers an area of more than 40,000 square meters and the Chinese medicinal materials base area is more than 6,000 mu. The company has complete modern production equipment such as pretreatment, extraction, concentration, granulation, tablet pressing, and packaging of traditional Chinese medicine, as well as granules, capsules, and tablet production lines, and has an independent traditional Chinese medicine research and development organization and a strong technical R&D team. The company has excellent quality inspection equipment and a strong quality inspection team, and a variety of processes and equipment have independent intellectual property rights. A mature marketing system covering the whole country and a high-quality marketing team and service network have been established. On the basis of win-win cooperation, it has established good cooperative relationships with many pharmaceutical companies across the country for many years. It has established a research and development base for traditional Chinese medicinal materials and Chinese patent medicine varieties with Chengdu University of Traditional Chinese Medicine and West China Medical University. Sichuan Taile Pharmaceutical Co., Ltd.'s products enjoy a good reputation nationwide. The company's annual production capacity reaches 1 billion capsules, 800 million granules, and 700 million tablets. The company's high-quality products and good after-sales service cover many large and medium-sized hospitals, direct-operated pharmacies and chain companies in 31 provinces, autonomous regions and municipalities across the country. The high-quality products benefit a wide range of consumer groups.
Sichuan Tailuo Pharmaceutical Co., Ltd.
Sichuan Taile Pharmaceutical Co., Ltd. was established in June 1999. It is a national high-tech enterprise mainly producing and selling traditional Chinese medicine granules, capsules and tablets. Located in Suining Economic and Technological Development Zone, the hometown of Guanyin in China, the company adheres to the business philosophy of "production according to law and establishing business honestly", and integrates the purpose of "making high-quality and secure medicines and protecting human health" into the entire process of enterprise production and operation. The company's factory covers an area of more than 40,000 square meters and the Chinese medicinal materials base area is more than 6,000 mu. The company has complete modern production equipment such as pretreatment, extraction, concentration, granulation, tablet pressing, and packaging of traditional Chinese medicine, as well as granules, capsules, and tablet production lines, and has an independent traditional Chinese medicine research and development organization and a strong technical R&D team. The company has excellent quality inspection equipment and a strong quality inspection team, and a variety of processes and equipment have independent intellectual property rights. A mature marketing system covering the whole country and a high-quality marketing team and service network have been established. On the basis of win-win cooperation, it has established good cooperative relationships with many pharmaceutical companies across the country for many years. It has established a research and development base for traditional Chinese medicinal materials and Chinese patent medicine varieties with Chengdu University of Traditional Chinese Medicine and West China Medical University. Sichuan Taile Pharmaceutical Co., Ltd.'s products enjoy a good reputation nationwide. The company's annual production capacity reaches 1 billion capsules, 800 million granules, and 700 million tablets. The company's high-quality products and good after-sales service cover many large and medium-sized hospitals, direct-operated pharmacies and chain companies in 31 provinces, autonomous regions and municipalities across the country. The high-quality products benefit a wide range of consumer groups.
Guangdong Jiaying Pharmaceutical Co., Ltd.
Guangdong Jiaying Pharmaceutical Co., Ltd. is a Chinese patent medicine pharmaceutical company integrating R&D, production and sales. The company was established in 2003 by the restructuring of Meizhou Pharmaceutical Factory in Guangdong Province. In December 2007, it was listed on the Shenzhen Stock Exchange. Stock abbreviation: Jiaying Pharmaceutical, stock code: 002198. At present, the company has two drug research and development, production and sales bases in Changsha City, Hunan Province and Meizhou City, Guangdong Province, with a total assets of more than 1 billion yuan and a total market value of nearly 3 billion yuan. The company has a total of 5 dosage forms and 70 drug approval numbers. The products include throat, cold, orthopedics, rheumatology, gynecology, heat clearance, nourishing, and gastrointestinal. The main products include Shuangliu Fengsan, Chonggui Ling tablet, Qiliu tablet (capsule), Shufenghuluo tablet, Menstrual regulation and blood circulation tablet, etc. Among them, Shuangliu Fengsan is developed using a century-old formula and is used in pharyngeal medicine. It has a high reputation and reputation and is very popular among consumers. The company has set up marketing offices in 30 provincial capital cities across the country and has established relatively stable cooperative relationships with thousands of pharmaceutical companies and more than 2,000 medical institutions. The company currently has more than 90 scientific and technological personnel and more than 1,000 production and sales employees. It has established a collaborative innovation cooperation relationship with many universities and research institutes. It has strong R&D capabilities in new products and is in the industry. front end. The type value of traditional Chinese medicine raw materials, the scale and technological content of the extraction and deep processing projects are industry benchmarks and are of great strategic significance for the development of the international market.
Guangdong Jiaying Pharmaceutical Co., Ltd.
Guangdong Jiaying Pharmaceutical Co., Ltd. is a Chinese patent medicine pharmaceutical company integrating R&D, production and sales. The company was established in 2003 by the restructuring of Meizhou Pharmaceutical Factory in Guangdong Province. In December 2007, it was listed on the Shenzhen Stock Exchange. Stock abbreviation: Jiaying Pharmaceutical, stock code: 002198. At present, the company has two drug research and development, production and sales bases in Changsha City, Hunan Province and Meizhou City, Guangdong Province, with a total assets of more than 1 billion yuan and a total market value of nearly 3 billion yuan. The company has a total of 5 dosage forms and 70 drug approval numbers. The products include throat, cold, orthopedics, rheumatology, gynecology, heat clearance, nourishing, and gastrointestinal. The main products include Shuangliu Fengsan, Chonggui Ling tablet, Qiliu tablet (capsule), Shufenghuluo tablet, Menstrual regulation and blood circulation tablet, etc. Among them, Shuangliu Fengsan is developed using a century-old formula and is used in pharyngeal medicine. It has a high reputation and reputation and is very popular among consumers. The company has set up marketing offices in 30 provincial capital cities across the country and has established relatively stable cooperative relationships with thousands of pharmaceutical companies and more than 2,000 medical institutions. The company currently has more than 90 scientific and technological personnel and more than 1,000 production and sales employees. It has established a collaborative innovation cooperation relationship with many universities and research institutes. It has strong R&D capabilities in new products and is in the industry. front end. The type value of traditional Chinese medicine raw materials, the scale and technological content of the extraction and deep processing projects are industry benchmarks and are of great strategic significance for the development of the international market.
Zhongshan Zhongzhi Pharmaceutical Group Co., Ltd.
Zhongshan Hengsheng Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Zhongzhi Pharmaceutical Group and a high-tech enterprise. It was formerly the Zhongshan Traditional Chinese Medicine Factory, which was established in 1954. It was reorganized in April 2000 and was subsequently relocated in accordance with the national GMP standards. Renovation and creation of new production bases have a long history of development. After relocated Hang Seng Pharmaceuticals fully passed the national drug GMP certification in 2004, passed the re-examination in 2008, and passed the 2010 version of GMP certification in 2013. It currently has granules, tablets, hard capsules, and mixtures (oral treatments). There are six major dosage forms including liquid), syrup and tea agents, and there are 60 drug approval documents. Among them, there are the core advantageous varieties "Zhongzhi Pai Keke Tablets" and "Zhongzhi Yinhuang Granules", the national traditional Chinese medicine protected variety "Patient Qixing Tea Oral Liquid", as well as "Shiqi External Tea", "Shiqi External Granules" and "Ginseng and Qi Oral Liquid" and other exclusive varieties or exclusive dosage forms nationwide. Advanced production equipment, excellent production environment and complete supporting hardware and software facilities are a good foundation for Hang Seng Pharmaceutical's large-scale production operation; the perfect quality assurance system provides high-quality guarantees for products; the continuous research and development of new products are Hang Seng Pharmaceutical. Provides sustainable development potential.
Zhongshan Zhongzhi Pharmaceutical Group Co., Ltd.
Zhongshan Hengsheng Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Zhongzhi Pharmaceutical Group and a high-tech enterprise. It was formerly the Zhongshan Traditional Chinese Medicine Factory, which was established in 1954. It was reorganized in April 2000 and was subsequently relocated in accordance with the national GMP standards. Renovation and creation of new production bases have a long history of development. After relocated Hang Seng Pharmaceuticals fully passed the national drug GMP certification in 2004, passed the re-examination in 2008, and passed the 2010 version of GMP certification in 2013. It currently has granules, tablets, hard capsules, and mixtures (oral treatments). There are six major dosage forms including liquid), syrup and tea agents, and there are 60 drug approval documents. Among them, there are the core advantageous varieties "Zhongzhi Pai Keke Tablets" and "Zhongzhi Yinhuang Granules", the national traditional Chinese medicine protected variety "Patient Qixing Tea Oral Liquid", as well as "Shiqi External Tea", "Shiqi External Granules" and "Ginseng and Qi Oral Liquid" and other exclusive varieties or exclusive dosage forms nationwide. Advanced production equipment, excellent production environment and complete supporting hardware and software facilities are a good foundation for Hang Seng Pharmaceutical's large-scale production operation; the perfect quality assurance system provides high-quality guarantees for products; the continuous research and development of new products are Hang Seng Pharmaceutical. Provides sustainable development potential.
Sichuan Taihuatang Pharmaceutical Co., Ltd.
Sichuan Taihuatang Pharmaceutical Co., Ltd. was founded in 1988 and is a modern pharmaceutical enterprise under the Sichuan Natural Resources Investment Group. Over the years, Taihuatang has always adhered to the spirit of "two bombs and one satellite", and has taken "leading modern science and technology and promoting traditional Chinese medicine culture" as its corporate mission, striving for excellence and developing distinctively. The company now covers an area of nearly 200 mu and has more than 1,000 employees. It has 8 national GMP production lines including capsules, tablets, oral liquids, and 82 products. The products involve multiple treatment areas such as nourishing and replenishing the body, digestive system, cardiovascular and cerebrovascular, tumor auxiliary drugs, gynecological drugs, antibiotics, antipyretic and analgesic drugs. The company is currently a high-tech enterprise in Sichuan Province and an independent intellectual property advantage enterprise in Sichuan Province.
Sichuan Taihuatang Pharmaceutical Co., Ltd.
Sichuan Taihuatang Pharmaceutical Co., Ltd. was founded in 1988 and is a modern pharmaceutical enterprise under the Sichuan Natural Resources Investment Group. Over the years, Taihuatang has always adhered to the spirit of "two bombs and one satellite", and has taken "leading modern science and technology and promoting traditional Chinese medicine culture" as its corporate mission, striving for excellence and developing distinctively. The company now covers an area of nearly 200 mu and has more than 1,000 employees. It has 8 national GMP production lines including capsules, tablets, oral liquids, and 82 products. The products involve multiple treatment areas such as nourishing and replenishing the body, digestive system, cardiovascular and cerebrovascular, tumor auxiliary drugs, gynecological drugs, antibiotics, antipyretic and analgesic drugs. The company is currently a high-tech enterprise in Sichuan Province and an independent intellectual property advantage enterprise in Sichuan Province.
Guangdong Kangqili Pharmaceutical Co., Ltd.
The company was founded in 1986 and was restructured into a joint-stock company in 2009. The company is located in Wuhua County, Meizhou City, a hometown of culture , football and overseas Chinese. Over the years, the Kangqili Health Industrial Park has been focused on the construction of the county development zone . The park covers an area of about 200,000 square meters and a total construction area of about 90,000 square meters. The construction of the park follows the concept of harmonious coexistence between man and nature, strives to maintain the original landform, the buildings are surrounded by mountains and rivers, the roads are rounded, and the green trees are full of vitality. The park's production, life and business facilities are perfect, and it is a "work is in the park." ” the park. The company has trained more than 300 employees through GMP, including 58 engineering and technical personnel of various types. In terms of talent reserve, it has been conducting "industry-university-research" cooperation with Guangzhou University of Traditional Chinese Medicine and other universities for many years , and has introduced scientific research institutions and talents to participate in the company's research and development of traditional Chinese medicine products. With innovation, we will continue to highlight the signs of "National High-tech Enterprise" and "Guangdong Provincial Traditional Chinese Patent Medicine Solid Preparation Engineering Technology Research Center" to maintain technological advantages.
Guangdong Kangqili Pharmaceutical Co., Ltd.
The company was founded in 1986 and was restructured into a joint-stock company in 2009. The company is located in Wuhua County, Meizhou City, a hometown of culture , football and overseas Chinese. Over the years, the Kangqili Health Industrial Park has been focused on the construction of the county development zone . The park covers an area of about 200,000 square meters and a total construction area of about 90,000 square meters. The construction of the park follows the concept of harmonious coexistence between man and nature, strives to maintain the original landform, the buildings are surrounded by mountains and rivers, the roads are rounded, and the green trees are full of vitality. The park's production, life and business facilities are perfect, and it is a "work is in the park." ” the park. The company has trained more than 300 employees through GMP, including 58 engineering and technical personnel of various types. In terms of talent reserve, it has been conducting "industry-university-research" cooperation with Guangzhou University of Traditional Chinese Medicine and other universities for many years , and has introduced scientific research institutions and talents to participate in the company's research and development of traditional Chinese medicine products. With innovation, we will continue to highlight the signs of "National High-tech Enterprise" and "Guangdong Provincial Traditional Chinese Patent Medicine Solid Preparation Engineering Technology Research Center" to maintain technological advantages.
Guangdong Zaitian Pharmaceutical Co., Ltd.
Guangdong Zaitian Pharmaceutical Co., Ltd. was established in May 2002. It is located at No. 10, Chuangxing Avenue, Qingyuan High-tech Industrial Development Zone, Guangdong, covering an area of 60 mu. It is a high-tech enterprise in Guangdong Province and a private science and technology enterprise in Guangdong Province. It has four pharmaceutical GMP production lines: granules, tablets, capsules, and lotions, as well as three health food GMP production lines: granules, tablets, and capsules. The company has a modern factory and office building quality inspection building, with an annual production capacity of 100 billion tablets, 1,500 tons of granules, 50 billion capsules, and 1 billion bottles of lotion. The independent quality inspection center is used to detect the quality of all product raw materials and finished products. It is equipped with gas chromatographs, ultraviolet spectrophotometers and other testing equipment and high-quality personnel to meet your high-quality requirements for products.
Guangdong Zaitian Pharmaceutical Co., Ltd.
Guangdong Zaitian Pharmaceutical Co., Ltd. was established in May 2002. It is located at No. 10, Chuangxing Avenue, Qingyuan High-tech Industrial Development Zone, Guangdong, covering an area of 60 mu. It is a high-tech enterprise in Guangdong Province and a private science and technology enterprise in Guangdong Province. It has four pharmaceutical GMP production lines: granules, tablets, capsules, and lotions, as well as three health food GMP production lines: granules, tablets, and capsules. The company has a modern factory and office building quality inspection building, with an annual production capacity of 100 billion tablets, 1,500 tons of granules, 50 billion capsules, and 1 billion bottles of lotion. The independent quality inspection center is used to detect the quality of all product raw materials and finished products. It is equipped with gas chromatographs, ultraviolet spectrophotometers and other testing equipment and high-quality personnel to meet your high-quality requirements for products.
Beijing Tong Ren Tang Group Co., Ltd.
A traditional Chinese medicine brand specializing in herbal remedies, including Yin Qiao Jie Du Ke Li for cold and flu symptoms.
Beijing Tong Ren Tang Group Co., Ltd.
A traditional Chinese medicine brand specializing in herbal remedies, including Yin Qiao Jie Du Ke Li for cold and flu symptoms.
A Japanese brand known for its traditional Kampo medicine, including Xiao Chai Hu Tang for immune support.
Tsumura & Co.
A Japanese brand known for its traditional Kampo medicine, including Xiao Chai Hu Tang for immune support.
Yunnan Baiyao Group Co., Ltd.
A renowned Chinese brand offering herbal remedies like Huo Xiang Zheng Qi for digestive and cold-related issues.
Yunnan Baiyao Group Co., Ltd.
A renowned Chinese brand offering herbal remedies like Huo Xiang Zheng Qi for digestive and cold-related issues.
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
A trusted brand offering herbal remedies, including Jin Yin Hua for respiratory health.
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
A trusted brand offering herbal remedies, including Jin Yin Hua for respiratory health.
Shijiazhuang Yiling Pharmaceutical Co., Ltd.
A leading brand in China, producing Lian Hua Qing Wen for cold and flu treatment.
Shijiazhuang Yiling Pharmaceutical Co., Ltd.
A leading brand in China, producing Lian Hua Qing Wen for cold and flu treatment.
Tianjin Chase Sun Pharmaceutical Co., Ltd.
A brand specializing in herbal formulas like Qing Fei Pai Du for respiratory health.
Tianjin Chase Sun Pharmaceutical Co., Ltd.
A brand specializing in herbal formulas like Qing Fei Pai Du for respiratory health.
Guangxi Wuzhou Pharmaceutical (Group) Co., Ltd.
A Chinese brand offering herbal remedies for pain relief and immune support.
Guangxi Wuzhou Pharmaceutical (Group) Co., Ltd.
A Chinese brand offering herbal remedies for pain relief and immune support.
